E-Pill Pharma Frequently Asked Questions (FAQ)
When was E-Pill Pharma founded?
E-Pill Pharma was founded in 2003.
What is E-Pill Pharma's latest funding round?
E-Pill Pharma's latest funding round is Other Investors.
Who are the investors of E-Pill Pharma?
Investors of E-Pill Pharma include GlenRock Israel and Pitango Venture Capital.
Who are E-Pill Pharma's competitors?
Competitors of E-Pill Pharma include Bioness, Celonova Biosciences, Neuronetics, Minimus Spine, Verifica BG and 7 more.
Compare E-Pill Pharma to Competitors
Leptos BioMedical is a company that operates in the online gaming and gambling industry, focusing on providing a variety of online slot games. The company offers a range of gaming services including high RTP (Return to Player) slots, progressive jackpots, and features such as free spins, catering to users interested in real money gaming. In addition to slots, Leptos BioMedical provides live casino games, sports betting, fishing games, lottery services, and poker rooms. It was founded in 2002 and is based in Fridley, Minnesota.
ImpediMed is a company that focuses on the development and distribution of medical devices, specifically in the healthcare sector. The company's main products are devices that utilize bioimpedance spectroscopy (BIS) technologies to noninvasively assess and monitor fluid status in patients, aiding in the clinical assessment of potential onset of secondary lymphoedema, particularly in cancer survivors. These devices are primarily used in the healthcare industry, particularly by surgeons, oncologists, therapists, and radiation oncologists. It is based in San Diego, California.
Alta Biomaterials specializes in proprietary medical device coating technologies within the biotechnology sector. The company offers surface modification solutions that improve biocompatibility, facilitate drug delivery, and provide anti-inflammatory and thromboresistant properties to medical devices. Alta Biomaterials primarily serves medical device original equipment manufacturers (OEMs) seeking to enhance the performance of their products. It is based in San Antonio, Texas.
NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.
C2C specializes in the contract manufacturing of medical devices, offering comprehensive services from product development to commercialization. The company provides expertise in design, prototyping, regulatory strategy, and pilot production, as well as manufacturing, packaging, labeling, and sterilization of medical devices. C2C primarily serves the medical device industry, catering to inventors and companies seeking to bring new products to market or scale existing ones. It is based in Melbourne, Florida.
Cerapedics is a privately held medical device company focused on developing and commercializing osteobiologic products based on its anorganic bone mineral (ABM) and synthetic small peptide (P-15) technology platform for use in a wide variety of spine, trauma and orthopedic surgical procedures. i-FACTOR bone graft is a biologic bone graft that utilizes a synthetic small peptide as an attachment factor intended to stimulate the natural bone healing process resulting in safe, predictable bone formation at a fraction of the cost of growth factors. It was founded in 2000 and is based in Westminster, Colorado.